Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding

Although confounding is an important problem of cohort studies, its effects can be minimised to enable valid comparison In cohort studies, who does or does not receive an intervention is determined by practice patterns, personal choice, or policy decisions. This raises the possibility that the intervention and comparison groups may differ in characteristics that affect the study outcome, a problem called selection bias. If these characteristics have independent effects on the observed outcome in each group, they will create differences in outcomes between the groups apart from those related to the interventions being assessed. This effect is known as confounding.1 In the first paper in the series we dealt with the design and use of cohort studies and how to identify selection bias.2 This paper focuses on the definition and assessment of confounders. For a characteristic to be a confounder in a particular study, it must meet two criteria.1 The first is that it must be related to the outcome in terms of prognosis or susceptibility. For example, in the study of the association between antipsychotic use and hip fracture that we considered in the first paper,2 age is known to be related to risk of hip fracture and therefore has the potential to be a confounder. The second criterion that defines a confounder is that the distribution of the characteristic is different in the groups being compared. It can differ in terms of either the mean or the degree of variation or variability in that characteristic. For example, for age to be a confounder in a cohort study, either the average age or the variation in the age in the groups being compared would have to be different. Assessing variation as well as average values is important because groups can have the same average value …

[1]  T. Masud,et al.  Epidemiology of falls. , 2001, Age and ageing.

[2]  Ping Li,et al.  Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding , 2005, BMJ : British Medical Journal.

[3]  P. Rosenbaum,et al.  Invited commentary: propensity scores. , 1999, American journal of epidemiology.

[4]  S. Boonen,et al.  Clinical Risk Factors for Hip Fracture in Elderly Women: A Case–Control Study , 2002, Journal of orthopaedic trauma.

[5]  Donald Rubin,et al.  Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.

[6]  W. Willett,et al.  Walking and leisure-time activity and risk of hip fracture in postmenopausal women. , 2002, JAMA.

[7]  Jacob Cohen Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[8]  H. Sox,et al.  Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease , 2002, Annals of Internal Medicine.

[9]  S. Schneeweiss,et al.  Association Between SSRI Use and Hip Fractures and the Effect of Residual Confounding Bias in Claims Database Studies , 2004, Journal of clinical psychopharmacology.

[10]  J. Playfer,et al.  Falls and Parkinson's disease. , 2001, Age and ageing.

[11]  S. Cummings,et al.  Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. , 1995, The New England journal of medicine.

[12]  D. Moher,et al.  The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.

[13]  Douglas G Altman,et al.  Treatment allocation in controlled trials: why randomise? , 1999, BMJ.

[14]  William R Shadish,et al.  Propensity Scores , 2005, Evaluation review.

[15]  S. Normand,et al.  Reader's guide to critical appraisal of cohort studies: 1. Role and design , 2005, BMJ : British Medical Journal.

[16]  D. Lawlor,et al.  Association between falls in elderly women and chronic diseases and drug use: cross sectional study , 2003, BMJ : British Medical Journal.

[17]  P. J. Bowman,et al.  Central nervous system active medications and risk for fractures in older women. , 2003, Archives of internal medicine.

[18]  P. J. Bowman,et al.  Central Nervous System–Active Medications and Risk for Falls in Older Women , 2002, Journal of the American Geriatrics Society.